SANOFI INDIA
Quarterly Results Analysis [Mar2025]
SANOFI INDIA Quarterly Results
Standalone | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 Audited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹536 Cr | ₹515 Cr | ₹524 Cr | ₹464 Cr | ₹511 Cr | ₹469 Cr | ₹491 Cr | ₹515 Cr |
Expenses | ₹364 Cr | ₹397 Cr | ₹404 Cr | ₹348 Cr | ₹374 Cr | ₹370 Cr | ₹377 Cr | ₹393 Cr |
Operating Income | ₹172 Cr | ₹118 Cr | ₹120 Cr | ₹116 Cr | ₹137 Cr | ₹100 Cr | ₹114 Cr | ₹122 Cr |
Other Income | ₹3 Cr | ₹6 Cr | ₹2 Cr | ₹5 Cr | ₹4 Cr | ₹9 Cr | ₹11 Cr | ₹16 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
Depreciation | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr |
Profit Before Tax | ₹165 Cr | ₹122 Cr | ₹113 Cr | ₹92 Cr | ₹105 Cr | ₹99 Cr | ₹115 Cr | ₹127 Cr |
Profit After Tax | ₹120 Cr | ₹91 Cr | ₹82 Cr | ₹68 Cr | ₹72 Cr | ₹70 Cr | ₹81 Cr | ₹81 Cr |
EPS | ₹51.96 | ₹39.70 | ₹35.74 | ₹29.65 | ₹31.30 | ₹30.30 | ₹35.04 | ₹35.22 |
Industry Peers & Returns | 1W | 1M | 1Y |
SANOFI INDIA | -0.6% | -2.9% | -7.9% |
SUN PHARMACEUTICAL INDUSTRIES | 3.6% | 2.5% | 6.2% |
DIVIS LABORATORIES | -2.9% | 1.5% | 48.1% |
CIPLA | -0.1% | -2.4% | -1.4% |
TORRENT PHARMACEUTICALS | 2.5% | 4.9% | 15.2% |
DR REDDYS LABORATORIES | -0.7% | -6.4% | -5.2% |
MANKIND PHARMA | 5% | 12% | 27.4% |
ZYDUS LIFESCIENCES | -1.1% | -0.7% | -16.8% |
LUPIN | 2% | -2.9% | 5.9% |
SANOFI INDIA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 4.08 % |
Y-o-Y | 4.91 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹536 Cr | 4.08 | |
Dec2024 | ₹515 Cr | -1.74 | |
Sep2024 | ₹524 Cr | 13.05 | |
Jun2024 | ₹464 Cr | -9.26 | |
Mar2024 | ₹511 Cr | 8.87 | |
Dec2023 | ₹469 Cr | -4.38 | |
Sep2023 | ₹491 Cr | -4.70 | |
Jun2023 | ₹515 Cr | - |
SANOFI INDIA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 45.31 % |
Y-o-Y | 25.38 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹172 Cr | 45.31 | |
Dec2024 | ₹118 Cr | -1.17 | |
Sep2024 | ₹120 Cr | 3.46 | |
Jun2024 | ₹116 Cr | -15.61 | |
Mar2024 | ₹137 Cr | 37.65 | |
Dec2023 | ₹100 Cr | -12.25 | |
Sep2023 | ₹114 Cr | -6.66 | |
Jun2023 | ₹122 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 39.60 % |
Y-o-Y | 19.52 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 32.08% | 39.60 | |
Dec2024 | 22.98% | 0.61 | |
Sep2024 | 22.84% | -8.49 | |
Jun2024 | 24.96% | -7.00 | |
Mar2024 | 26.84% | 26.42 | |
Dec2023 | 21.23% | -8.21 | |
Sep2023 | 23.13% | -2.07 | |
Jun2023 | 23.62% | - |
SANOFI INDIA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 30.89 % |
Y-o-Y | 65.97 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹120 Cr | 30.89 | |
Dec2024 | ₹91 Cr | 11.07 | |
Sep2024 | ₹82 Cr | 20.53 | |
Jun2024 | ₹68 Cr | -5.28 | |
Mar2024 | ₹72 Cr | 3.30 | |
Dec2023 | ₹70 Cr | -13.52 | |
Sep2023 | ₹81 Cr | -0.49 | |
Jun2023 | ₹81 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 25.78 % |
Y-o-Y | 58.16 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 22.3 % | 25.78 | |
Dec2024 | 17.73 % | 13.00 | |
Sep2024 | 15.69 % | 6.66 | |
Jun2024 | 14.71 % | 4.33 | |
Mar2024 | 14.1 % | -5.11 | |
Dec2023 | 14.86 % | -9.56 | |
Sep2023 | 16.43 % | 4.45 | |
Jun2023 | 15.73 % | - |
SANOFI INDIA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 30.88 % |
Y-o-Y | 66.01 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹51.96 | 30.88 | |
Dec2024 | ₹39.7 | 11.08 | |
Sep2024 | ₹35.74 | 20.54 | |
Jun2024 | ₹29.65 | -5.27 | |
Mar2024 | ₹31.3 | 3.30 | |
Dec2023 | ₹30.3 | -13.53 | |
Sep2023 | ₹35.04 | -0.51 | |
Jun2023 | ₹35.22 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD